Cargando…

Use of Lipid-Lowering Medications and the Likelihood of Achieving Optimal LDL-Cholesterol Goals in Coronary Artery Disease Patients

Background. In clinical practice, most coronary artery disease patients are not achieving their recommend LDL-cholesterol goal of <70 mg/dL. Methods. We conducted a retrospective analysis of outpatient electronic health records and the most recent lipid profile, lipid-lowering medications and dos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karalis, Dean G., Victor, Brett, Ahedor, Lilian, Liu, Longjian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410303/ https://www.ncbi.nlm.nih.gov/pubmed/22888414 http://dx.doi.org/10.1155/2012/861924

Ejemplares similares

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions
por: Zhang, Shuang, et al.
Publicado: (2022)

Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University Hospital
por: Sangsawang, Tamon, et al.
Publicado: (2015)

Effect of alirocumab dose increase on LDL lowering and lipid goal attainment in patients with dyslipidemia
por: Kastelein, John J.P., et al.
Publicado: (2017)

New and emerging lipid-modifying drugs to lower LDL cholesterol
por: Kosmas, Constantine E, et al.
Publicado: (2021)

Lipid lowering therapy in primary and secondary prevention in Austria: are LDL-C goals achieved?: Results from the DA VINCI study
por: Siostrzonek, Peter, et al.
Publicado: (2021)

Reasons Why Combination Therapy Should Be the New Standard of Care to Achieve the LDL-Cholesterol Targets: Lipid-lowering combination therapy
por: Masana, Lluís, et al.
Publicado: (2020)

Physicians’ behavior following changes in LDL cholesterol target goals
por: Vinker, Shlomo, et al.
Publicado: (2015)

Lipid-Lowering Therapy after Acute Coronary Syndrome in Outpatient Practice—How to Achieve Goal
por: Rajtar-Salwa, Renata, et al.
Publicado: (2023)

Cardiovascular mortality after intensive LDL-Cholesterol lowering: Does baseline LDL-Cholesterol really matter?
por: Khan, Safi U., et al.
Publicado: (2020)

LDL-cholesterol goal attainment under persistent lipid-lowering therapy in northeast China: Subgroup analysis of the dyslipidemia international study of China (DYSIS-China)
por: Zheng, Wen, et al.
Publicado: (2017)

Evaluation of LDL goal achievement in statin consumption, south east of Iran
por: Aghasizadeh, Malihe, et al.
Publicado: (2021)

Clinical and Economic Benefits Associated With the Achievement of Both HbA(1c) and LDL Cholesterol Goals in Veterans With Type 2 Diabetes
por: Shi, Lizheng, et al.
Publicado: (2013)

Intensive lipid-lowering therapy for early achievement of guideline-recommended LDL-cholesterol levels in patients with ST-elevation myocardial infarction (“Jena auf Ziel”)
por: Makhmudova, Umidakhon, et al.
Publicado: (2023)

Factors associated with unattained LDL-cholesterol goals in Chinese patients with acute coronary syndrome one year after percutaneous coronary intervention
por: Zhang, Wenduo, et al.
Publicado: (2017)

Role of Lipid-Lowering Therapy in Low-Density Lipoprotein Cholesterol Goal Attainment: Focus on Patients With Acute Coronary Syndrome
por: Wang, Qinqin, et al.
Publicado: (2020)

Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?
por: Clem, James R, et al.
Publicado: (2009)

The evaluation of low-density lipoprotein cholesterol goals achieved in patients with established cardiovascular disease and/or hyperlipidaemia receiving lipid-lowering therapy: the South African Not At Goal study (SA-NAG)
por: Ramjeeth, Akash, et al.
Publicado: (2008)

Implications of the obesity epidemic for lipid-lowering therapy: Non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target
por: Hoenig, Michel R
Publicado: (2008)

Can we achieve ESC 2019 guidelines LDL-cholesterol target in Tunisia?
por: Ibn Elhadj, Zied, et al.
Publicado: (2022)

Trends in low-density lipoprotein cholesterol goal achievement and changes in lipid-lowering therapy after incident atherosclerotic cardiovascular disease: Danish cohort study
por: Ersbøll, Annette Kjær, et al.
Publicado: (2023)

A Retrospective Cohort Study of the Potency of lipid-lowering therapy and Race-gender Differences in LDL cholesterol control
por: Turner, Barbara J, et al.
Publicado: (2011)

When LDL Cholesterol Is Not LDL Cholesterol: LpX, A Clinical Lesson
por: Huygen, Lisa P.M., et al.
Publicado: (2022)

The DA VINCI study: is Ireland achieving ESC/EAS guideline–directed LDL-C goals?
por: Offiah, Gregory, et al.
Publicado: (2022)

Short-term LDL cholesterol-lowering efficacy of plant stanol esters
por: Hallikainen, Maarit, et al.
Publicado: (2002)

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
por: Storey, Benjamin C., et al.
Publicado: (2018)

The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials
por: Daida, Hiroyuki, et al.
Publicado: (2019)

Preliminary Pilot Study of Combined Effects of Physical Activity and Achievement of LDL-Cholesterol Target on Coronary Plaque Volume Changes in Patients with Acute Coronary Syndrome
por: Nishitani-Yokoyama, Miho, et al.
Publicado: (2020)

LDL‐cholesterol and PCSK9 in patients with familial hypercholesterolemia: influence of PCSK9 variants under lipid‐lowering therapy
por: Hamasaki, Masato, et al.
Publicado: (2021)

Remnant cholesterol but not LDL cholesterol is associated with 5-year bleeding following percutaneous coronary intervention
por: Li, Jiawen, et al.
Publicado: (2023)

Lower plasma cholesterol, LDL-cholesterol and LDL-lipoprotein subclasses in adult phenylketonuria (PKU) patients compared to healthy controls: results of NMR metabolomics investigation
por: Cannet, Claire, et al.
Publicado: (2020)

Adherence to Statin Therapy and Attainment of LDL Cholesterol Goal Among Patients with Type 2 Diabetes and Dyslipidemia
por: Alwhaibi, Monira, et al.
Publicado: (2019)

Statin treatment and LDL-cholesterol treatment goal attainment among individuals with familial hypercholesterolaemia in primary care
por: Iyen, Barbara, et al.
Publicado: (2021)

Triglyceride and Small Dense LDL-Cholesterol in Patients with Acute Coronary Syndrome
por: Hori, Masakazu, et al.
Publicado: (2021)

LDL-Cholesterol Lowering of Plant Sterols and Stanols—Which Factors Influence Their Efficacy?
por: Trautwein, Elke A., et al.
Publicado: (2018)

Statin Intensity or Achieved LDL? Practice-based Evidence for the Evaluation of New Cholesterol Treatment Guidelines
por: Ross, Elsie Gyang, et al.
Publicado: (2016)

Targeting LDL Cholesterol With LNA
por: Krieg, Arthur M
Publicado: (2012)

Cellular itinerary of LDL cholesterol
por: Vance, Jean E.
Publicado: (2022)

Discordance of Non-HDL and Directly Measured LDL Cholesterol: Which Lipid Measure is Preferred When Calculated LDL Is Inaccurate?
por: Baruch, Lawrence, et al.
Publicado: (2013)

Historical Review of the Use of Relative Risk Statistics in the Portrayal of the Purported Hazards of High LDL Cholesterol and the Benefits of Lipid-Lowering Therapy
por: Diamond, David M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mb98ef7f0gg5796mdigf2k1hrk